Publications by authors named "Natalia Kubanek"
Article Synopsis
- Severe alcohol-associated hepatitis (SAH) is a serious condition with high mortality rates, and current treatments like corticosteroids have limited effectiveness, prompting the exploration of new therapies such as fecal microbiota transplantation (FMT).
- This study aimed to investigate the impact of FMT on 30- and 90-day mortality in SAH patients who did not respond to or were ineligible for corticosteroids, as well as to identify outcomes and factors influencing patient survival.
- The research involved a prospective analysis of adult patients receiving FMT, comparing their outcomes with a control group who received standard care, and evaluating various prognostic factors related to SAH outcomes.
Background And Aims: Intestinal inflammation assessed by fecal calprotectin (F-CAL) in advanced chronic liver disease (ACLD) may represent an early sign of intestinal barrier dysfunction. We aimed to explore the usefulness of F-CAL testing in ACLD in the prediction of adverse outcomes (AO, death, or LT) and refinement of prognostic stratification.
Patients And Methods: We explored the RH7 cirrhosis registry comprising consecutive hospitalized patients and a control group with data on disease phenotype, demographics, anthropometrics, prognostic indices, and medication.
Background And Aims: Alcohol-associated hepatitis (AH) poses significant short-term mortality. Existing prognostic models lack precision for 90-day mortality. Utilizing artificial intelligence in a global cohort, we sought to derive and validate an enhanced prognostic model.
View Article and Find Full Text PDFBackground: Alcohol-associated hepatitis (AH) is a severe inflammatory form of alcohol-associated liver disease (ALD) that carries a high mortality rate. Early liver transplantation for severe AH is increasingly available. However, specific criteria for referral and selection remain a subject of debate.
View Article and Find Full Text PDF